Showing results (441-450 of 15,740) with videos related to

Sort By:
Pageof 1,574
The Journal of Antimicrobial Chemotherapy|February 9, 2022
Are infants exposed to antimicrobials during the first 3 months of life at increased risk of recurrent use? An explorative data-linkage studyChristian Magnus Thaulow, Stig Harthug, Roy Miodini Nilsen, et al.
The Journal of Antimicrobial Chemotherapy|February 2, 2022
Correlation of antimicrobial fraction unbound and sieving coefficient in critically ill patients on continuous renal replacement therapy: a systematic reviewJulie E Farrar, Scott W Mueller, Victoria Stevens, et al.
The Journal of Antimicrobial Chemotherapy|February 2, 2022
Phenotypic and genomic analysis reveals Riemerella anatipestifer as the potential reservoir of tet(X) variantsRuichao Li, Yongjia Jiang, Kai Peng, et al.
The Journal of Antimicrobial Chemotherapy|February 2, 2022
Prevalence and patterns of HIV drug resistance in patients with suspected virological failure in North-Western TanzaniaShimba Henerico, Sello Given Mikasi, Samuel Elias Kalluvya, et al.
The Journal of Antimicrobial Chemotherapy|February 2, 2022
Simultaneous pharmacokinetic/pharmacodynamic (PKPD) assessment of ampicillin and gentamicin in the treatment of neonatal sepsisSilke Gastine, Christina Obiero, Zoe Kane, et al.
The Journal of Antimicrobial Chemotherapy|February 2, 2022
Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loadsAnne-Grete Märtson, Marieke G G Sturkenboom, Marjolein Knoester, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1986
Antibiotic prophylaxis in vascular reconstructive surgery: a double-blind placebo-controlled studyA M Worning, N Frimodt-Møller, P Ostri, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2019
Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, Phase II trial (CLEAR)Vassiliki Dimitriou, Lena M Biehl, Axel Hamprecht, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2019
Antibacterial effect of imipenem/relebactam on aerobic Gram-negative bacilli: in vitro simulations of 7 or 14 day human exposuresAlan R Noel, Karen E Bowker, Marie Attwood, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2019
Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in MexicoMaria F Gonzalez-Lara, Carla M Roman-Montes, Paulette Diaz-Lomeli, et al.
Pageof 1,574